Investigating how new medications for drug addiction are processed in the body
Official title: IN VITRO METABOLISM AND NON-CLINICAL ADME STUDIES IDIQ CONTRACT. POP 9/27/21-9/26/26. NTE $3.5 MILLION.
Funded at Sri International · NIH-10937509 · Data updated 2026-11-12
This study is looking at new medications to help people struggling with drug addiction by figuring out how these drugs work in the body, so that one day, patients can have safer and better treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project start | September 27, 2021 |
| Project end | September 26, 2026 |
| Funding year | 2023 |
| Award (this year) | $32,796 |
| NIH project number | 75N95021D00025-P00006-9999-3 |
| Project ID | NIH-10937509 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals struggling with drug addiction who may benefit from new treatment options.
✕Less likely to help
Patients who are not currently affected by drug addiction may not receive any benefit from this research.
What this research studies
This research focuses on developing new medications to treat drug addiction by studying how these drugs are absorbed, distributed, metabolized, and excreted in the body. It involves laboratory evaluations and nonclinical studies to understand the pharmacological and toxicological effects of these medications before they are tested in humans. Patients may benefit from the eventual development of safer and more effective treatments for addiction based on the findings of this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective medications for treating drug addiction.
How similar studies have gone: Previous research in drug metabolism and medication development has shown success in creating effective treatments for various conditions, indicating a promising approach.
Where this research is happening
-
Sri International
Menlo Park, United States Active
Researchers
- Principal investigator: Iyer, Lalitha V — Sri International
- Study coordinator: Iyer, Lalitha V
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.